31 results
8-K
EX-99.2
TMCI
Treace Medical Concepts Inc
27 Feb 24
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
4:13pm
Adjusted EBITDA breakeven in 2024 and cash flow positive in 2025 15 Total available access to liquidity, including debt facility, is ~$190 million Solidly
8-K
EX-99.1
TMCI
Treace Medical Concepts Inc
9 Jan 24
Regulation FD Disclosure
6:19pm
access to liquidity, including debt facility, is ~$185 million Solidly on Pathway Towards Sustainable Profitability¹ Jen Lapiplasty® patient
Solid footing
8-K
EX-99.1
imzqupw3qz2kk
3 May 22
Treace Secures Up to $150 Million in Debt Financing
7:11pm
DEF 14A
gce5ddb3qr1odw r24h
4 Apr 22
Definitive proxy
4:31pm
10-K
zcfeguw79pn1yxv33
4 Mar 22
Annual report
4:06pm
10-Q
xhsue raesubl
25 May 21
Quarterly report
4:08pm